Aldeyra Therapeutics, Inc.

Q3 2024 13F Holders

Symbol
ALDX
CUSIP
01438T106
Type
Equity
Class
COM
Num filers
114
Total reported value, excl. options
$250M
Manager Report Date Value ($000) Shares